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Intravital imaging enables [16_TD$DIFF]to study [4_TD$DIFF]
dynamic tumour–stroma interac-
tions within primary and metastatic
sites, including the lung. The com-
bination of optical windows with
speciﬁc molecular probes target-
ing the tumour microenvironment
will provide new insights into
prometastatic stromal interactions
and lead to novel therapeutic strat-
egies for metastatic diseases.
Cellular Interactions in the
Tumour Microenvironment
Malignant tumour cells frequently metasta-
sise to distant organs, such as the bone,
liver, brain, and lung, [17_TD$DIFF]which dramatically
reduces the survival rate of patients with
cancer. To establish metastatic tumours,
cancer cells egress from primary sites
through local invasion and intravasation (i.
e., entrance into lymphatic or blood ves-
sels), since the elaboration of such vessels
is enhancedduring tumour growth. Follow-
ing escape into the circulatory system, they
need to extravasate (i.e., escape from lym-
phatic or blood vessels), become estab-
lished, and proliferate at metastatic sites.
During thisprocess,metastatic cancer cells
also need to escape from the immune sur-
veillance of CD8+[15_TD$DIFF] T and natural killer (NK)
cells. Recent studies have shown that all of
these events are promoted by stromal[6_TD$DIFF] cells[3_-
TD$DIFF], such as endothelial cells, ﬁbroblasts,
and tumour-inﬁltrating immune cells, espe-
cially neutrophils and macrophages [1].
Since stromal cells also contribute to
chemotherapy resistance in malignant
tumours [2], tumour–stroma interactions
are considered[18_TD$DIFF] as promising targets for
[19_TD$DIFF]improved anticancer therapies. Therefore,
it has become essential to analyse the
dynamic behaviour of stromal cells to
understand how andwhy they interact with
cancer cells in the tumour microenviron-
ment, and the pro- or antitumoural conse-
quences of these interactions.
Intravital Imaging Windows
Over the past few years, intravital optical
imaging has been used to examine com-
plex biological events in vivo with subcellu-
lar resolution. For example, the groups of
Friedl and [20_TD$DIFF]Condeelis, Segall, andvanRhee-
nen were some of the ﬁrst to image sub-
cutaneousandmammary tumours via[21_TD$DIFF] skin-
fold chambers or optical windows [3,4].
The development of this technology has
opened the possibility to study in vivo key
processes that had been previously
described in the tumourmicroenvironment,
such as ﬁndings from the Sahai lab show-
ing that cancer-associated ﬁbroblasts are
necessary to enable the collective invasion
of tumour cells [5], or the paracrine loop
between tumour-associated macro-
phages and cancer cells in tumour cell
invasion and intravasation described by
Condeelis and coworkers [6].
Although most imaging studies to date
have focussed on primary tumours, Sip-
kins et al. imaged the bone marrow under
the thin mouse skull to identify that leukae-
mia bonemetastasis is initiated at a unique
bone marrow vascular area where the
endothelium secretes chemokine SDF-1/
CXCL12 [7]. Furthermore, recent advan-
ces in optical windows have enabled
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Figure 1. ImagingWindows to Study Tumour–Stroma Interactions in vivo. Superﬁcial primary tumours,
such as subcutaneous tumours and mammary tumours, can be imaged through[7_TD$DIFF] skin-fold chambers or optical
windows inserted into the skin over the tumour. These studies have accelerated the study of the kinetics of
angiogenesis during tumour development, the immune [8_TD$DIFF]response from CD8+ T and [9_TD$DIFF]NK[3_TD$DIFF] cells against tumour cells,
and the tumour cell invasion and intravasation guided by cancer-associated ﬁbroblasts or tumour-associated
macrophages. Metastatic tumours in the liver, brain, and lung can be imaged through optical windows (e.g.,
abdominal, cranial, and thoracic windows, respectively). Intravital microscopy through these windows has [10_TD$DIFF]been
used to analyse the dynamics of metastasised tumour cells (e.g., protrusion formation, premetastasis develop-
ment, perivascular, or angiogenic growth) as well as their interaction with macrophages.
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researchers to image metastatic tumours
in vital organs, such as the brain or liver
(Figure 1). For instance, Kienast et al.
imaged the development of metastatic
tumours in the brain via cranial windows
(i.e., windows implanted in the skulls of
mice) to identify the rate-limiting steps in
the formation of macrometastasis, such
as perivascular growth by angiogenesis
or vessel co-option [7]. Using an abdomi-
nal imaging window, Ritsma et al. visual-
ised liver metastasis and observed that
extravasated tumour cells proliferated
and formed premicrometastases where
individual cells were motile and lacked
contact with neighbouring tumour cells
[7]. Imaging subcutaneous tumours that
are transferred with ﬂuorescently labelled
CD8+ T and NK cells has also evidenced
the contacts between tumour cells and
the cytotoxic immune cells aiming to elim-
inate them [7].
Imaging these processes in the lung,
another major metastatic site, has been
challenging because it is a vital organ in
continuous motion and is enclosed within
the thoracic cavity. Nevertheless, Enten-
berg et al. recently succeeded in imaging
metastatic tumours in the breathing lung
with subcellular resolution using a vacuum
window and signal optimisation techni-
ques [8]. The high resolution of this new
technology allowed the authors to visual-
ise how tumour cells exhibit protrusions to
move inside the vessels immediately upon
arrival at the capillary. The authors also
showed myeloid cells (e.g., tumour-asso-
ciated macrophages) interacting directly
with tumour cells, which suggests their
critical role in the formation of metastatic
niches. Using a similar model, Headley
et al. recently imaged how microparticles
secreted by tumour cells are ingested by
macrophages in the lung and how they
upregulate a variety of adhesion and che-
motactic receptors [9]. Although visualis-
ing the lung via these windows is currently
limited to short imaging sessions (e.g.,
less than 24 h), these studies corroborate
the power of intravital imaging to study the
dynamics of tumour and stromal cells in
lung metastatic sites and provide new
insights into the cellular interactions that
regulate the establishment of lethal meta-
static tumours.
Activatable Molecular Probes
To be detected by intravital microscopy,
the cells of interest (e.g., stromal or cancer
cells) must be ﬂuorescently labelled,
although recent advances in coherent
anti-Stokes Raman scattering (CARS)
may provide a label-free optical imaging
platform in the near future. This labelling
can be readily achieved in transgenic ani-
mals where ﬂuorescent proteins (e.g.,
eCFP, eGFP, RFP, and mCherry) are
expressed under lineage-speciﬁc pro-
moters. However, this [22_TD$DIFF]approach often can-
not discriminate between speciﬁc cell
subpopulations [e.g.,macrophages versus
neutrophils (LysM promoter) or tissue-
resident versus recruited macrophages
(Csf1r promoter)], and often requires
multiple genetic crosses that are expensive
and time-consuming. Alternatively, speciﬁc
cells can be isolated, labelled with ﬂuores-
cent dyes (e.g., CFSEorCMTMR) and then
adoptively transferred to track their fate in
vivo. However, these labelling methods are
short-lived (e.g., less than a week) and the
transfer of large numbers of cells can lead
to artefacts. Fluorescently labelled antibod-
ies can be used to stain speciﬁc markers in
vivo, but their tissuedistribution, permeabil-
ity, and immunogenicity are a cause for
major concern. Another attractive strategy
involves the administration of activatable
molecular probes that emit a ﬂuorescent
signal only after they are activated by spe-
ciﬁc enzymes (e.g., matrix metallopro-
teases or myeloperoxidases) or in deﬁned
intracellular environments (e.g., low-pH
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Figure 2. Activatable Molecular Probes for Imaging Stromal Cells. (A) Peptide sequences can be
conjugated to quenched ﬂuorophores to produce activatable molecular probes that emit ﬂuorescence only after
cleavage by speciﬁc proteins (e.g., ﬁbroblast activating protein) [10]; (B) an internally[11_TD$DIFF]-quenched ﬂuorophore
(SNAPF), which reacts with hypochlorite (OCl–) produced by the myeloperoxidase enzyme, allows the mon-
itoring of activated neutrophils in the lung by ﬂuorescence imaging [11]; (C) PhagoGreen is a pH-sensitive
BODIPY ﬂuorophore for imaging phagocytic macrophages in vivo [12].
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organelles). Several activatable molecular
probes have been designed to track
tumour or stromal cells aswell as to provide
a direct readout of cellular or enzymatic
activity (Figure 2). These include ﬂuores-
cently labelled inhibitors or quenched pep-
tides to image protease activity (e.g., matrix
metalloproteases in cancer cells or ﬁbro-
blast activation protein in cancer-associ-
ated ﬁbroblasts [10]), ﬂuorescent probes
activated by myeloperoxidase for monitor-
ing activated neutrophils and alveolar mac-
rophages in the lungs [11], or pH-sensitive
probes for imaging phagocytic macro-
phages in vivo[23_TD$DIFF] [12].
Concluding Remarks
Activatable ﬂuorescent probes are a
powerful toolbox formonitoringdistinctpop-
ulations of stromal cells in vivo and for study-
ing their unique functions in subsets of cells
without the need for transgenic manipula-
tion. Furthermore, molecular probes can be
designed to target speciﬁc metabolites,
which might enable researchers to monitor
themetabolic activity of different cell types in
the tumour microenvironment. However,
the integration of molecular probes to intra-
vital imaging is not straightforward because
the cellular complexity of the tumour micro-
environment demands probes with very
high selectivity. To this end, the incorpo-
ration of other biomolecules (e.g., peptides,
small proteins, or drug molecules) might be
necessary to image speciﬁc subsets of cells.
The optimisation of molecular probes must
also address other important factors, such
as their biodistribution and kinetics, to
ensure that real-time intravital imaging can
be performed at the site of action. Bearing
these challenges in mind, we envisage that
the combination of high-resolution optical
imaging windows with molecular probes
targeting key events in the metastatic cas-
cade will become an excellent partnership
to understand the biology behind the pro-
gression ofmetastasis aswell as to evaluate
new anticancer therapies in situ and in
real time[24_TD$DIFF].
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